A drug delivery system using curcumin - the main ingredient in the spice turmeric - has been developed to successfully inhibit bone cancer cells while promoting growth of healthy bone cells. Researchers say this work could lead to better post-operative treatments for people with osteosarcoma, the second most prevalent cause of cancer death in children.